Encompass Health Corporation (NYSE: EHC) reported Q2 EPS of $1.17, $0.20 better than the analyst estimate of $0.97. Revenue for the quarter came in at $1.29 billion versus the consensus estimate of $1.26 billion.

GUIDANCE:

Encompass Health Corporation sees FY2021 EPS of $4.32-$4.47, versus the consensus of $4.11. Encompass Health Corporation sees FY2021 revenue of $5.1-5.25 billion, versus the consensus of $5.14 billion.

For earnings history and earnings-related data on Encompass Health Corporation (EHC) click here.